These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6346802)

  • 1. Preclinical studies on human insulin. II. General pharmacological studies.
    Jørgensen KD; Wolffbrandt KH; Weis JU
    Acta Pharmacol Toxicol (Copenh); 1983 Apr; 52(4):268-72. PubMed ID: 6346802
    [No Abstract]   [Full Text] [Related]  

  • 2. [Restoration processes in the cells of the pancreatic island apparatus in alloxan diabetic rats under the influence of RNA].
    Breslavskiĭ AS; Maksimov SV; Lapynina LA; Magkaeva LB
    Fiziol Zh; 1978; 24(1):23-8. PubMed ID: 342288
    [No Abstract]   [Full Text] [Related]  

  • 3. (-)-BM 13.0913: a new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non-insulin-dependent) diabetes mellitus.
    Freund P; Wolff HP; Kühnle HF
    Metabolism; 1995 May; 44(5):570-6. PubMed ID: 7752903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycaemic control with insulin prevents the reduced renal dopamine D1 receptor expression and function in streptozotocin-induced diabetes.
    Moreira-Rodrigues M; Quelhas-Santos J; Serrão P; Fernandes-Cerqueira C; Sampaio-Maia B; Pestana M
    Nephrol Dial Transplant; 2010 Sep; 25(9):2945-53. PubMed ID: 20339101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interaction of biguanides and exogenous insulin. An experimental study].
    Sterne J; Le Guilcher S
    Diabete; 1972; 20(1):43-8. PubMed ID: 5082058
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of 6-oxo-prostaglandin F1alpha by rat aorta: influence of diabetes, insulin treatment, and caloric deprivation.
    Rogers SP; Larkins RG
    Diabetes; 1981 Nov; 30(11):935-9. PubMed ID: 7028546
    [No Abstract]   [Full Text] [Related]  

  • 7. The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats.
    Katsumata K; Katsumata Y
    Horm Metab Res; 1990 Jan; 22(1):51-2. PubMed ID: 2106472
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of the effects of insulin, bradykinin, and captopril on blood glucose levels of alloxan-diabetic rats.
    Jaffa AA; Pratt J; Ashford A; Bailey GS
    Adv Exp Med Biol; 1986; 198 Pt B():373-8. PubMed ID: 3028079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin potentiating effect on development of alloxan diabetes and its prevention by the Ca-channel blocker nicardipine.
    Katsumata K; Miyao M; Katsumata Y
    Horm Metab Res; 1998 Sep; 30(9):557-8. PubMed ID: 9808323
    [No Abstract]   [Full Text] [Related]  

  • 10. Physiologic and cellular insulin action in a glucose-intolerant model of type 2 (non-insulin-dependent) diabetes in rats.
    Maloff BL; Boyd BK
    Diabetologia; 1986 May; 29(5):295-300. PubMed ID: 3522328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the pharmacological properties of pituitary and biosynthetic human growth hormone. Demonstration of antinatriuretic/antidiuretic and barbital sleep effects of human growth hormone in rats.
    Jørgensen KD
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):124-31. PubMed ID: 3811769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound M & B 39890A [N-(3-imidazol-1-ylpropyl)- 2-(3-trifluoromethylbenezensulphonamido)-benzamide hydrochloride], a glucagon and insulin secretion inhibitor, improves insulin sensitivity in viable yellow obese-diabetic mice.
    Yen TT; Schmiegel KK; Gold G; Williams GD; Dininger NB; Broderick CL; Gill AM
    Arch Int Pharmacodyn Ther; 1991; 310():162-74. PubMed ID: 1772327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of insulin on blood, plasma, and brain glucose in hyperglycemic diabetic rats.
    Hofer RE; Lanier WL
    Stroke; 1991 Apr; 22(4):505-9. PubMed ID: 1902600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro insulin action on erythrocyte glucose metabolism in normal and diabetic rats.
    Agarwal VR; Rastogi AK; Sagar P
    Diabetologia; 1988 Jan; 31(1):51-3. PubMed ID: 3127260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycemic and antihyperglycemic effect of leaves of Vinca rosea linn.
    Chattopadhyay RR; Sarkar SK; Ganguly S; Banerjee RN; Basu TK
    Indian J Physiol Pharmacol; 1991 Jul; 35(3):145-51. PubMed ID: 1791053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glyburide in a rat model of reduced B-cell mass.
    Leahy JL; Samols MD; Weir GC
    Prog Clin Biol Res; 1988; 265():87-98. PubMed ID: 3136456
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin Treatment Cannot Promote Lipogenesis in Rat Fetal Lung in Gestational Diabetes Mellitus Because of Failure to Redress the Imbalance Among SREBP-1, SCAP, and INSIG-1.
    Li J; Qian G; Zhong X; Yu T
    DNA Cell Biol; 2018 Mar; 37(3):264-270. PubMed ID: 29356579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current views on the mode of action of hypoglycemic sulfonamides].
    Creutzfeldt W
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():201-15. PubMed ID: 4906019
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversibility of diabetes- and diuresis-induced alterations in rat bladder dome muscarinic receptors.
    Fukomoto Y; Yoshida M; Weiss RM; Latifpour J
    Diabetes; 1994 Jun; 43(6):819-26. PubMed ID: 8194669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External control of drug release: controlled release of insulin from a hydrophilic polymer implant by ultrasound irradiation in diabetic rats.
    Miyazaki S; Yokouchi C; Takada M
    J Pharm Pharmacol; 1988 Oct; 40(10):716-7. PubMed ID: 2907539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.